Current role of radiation therapy in the management of histiocytosis-X.
With increasing utilization of systemic agents such as prednisone, oral alkylating agents and the vinca alkyloids, the use of radiation has decreased. In this article, current indications for radiation therapy are presented and recommended techniques and dose fractionation discussed.
Cassady
J R
JR
Department of Radiation Oncology, College of Medicine, University of Arizona, Tucson.
D006646:Histiocytosis, Langerhans-Cell / Q000150:complications / Q000532:radiotherapy*; D006801:Humans; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage